Sleep Aids (Pharmacies) - Northern Europe

  • Northern Europe
  • Revenue in the Sleep Aids market is projected to reach US$18.36m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.18%, resulting in a market volume of US$20.45m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$1,473.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.54 are generated in 2024.

Key regions: United States, Germany, Australia, India, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Sleep Aids (Pharmacies) market in Northern Europe is experiencing significant growth due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors.

Customer preferences:
Customers in Northern Europe are increasingly seeking sleep aids to address their sleep-related issues. Factors such as high-stress levels, long working hours, and busy lifestyles have contributed to an increase in sleep disorders among the population. As a result, there is a growing demand for sleep aids that can help individuals improve their sleep quality and overall well-being.

Trends in the market:
One of the key trends in the Sleep Aids (Pharmacies) market in Northern Europe is the rising popularity of natural and herbal sleep aids. Customers are becoming more conscious about the ingredients used in sleep aids and are opting for products that are free from artificial additives and chemicals. This trend is driven by the growing awareness of the potential side effects associated with traditional sleep medications. Another trend in the market is the increasing availability of sleep aids in different forms. Customers now have a wide range of options to choose from, including pills, sprays, teas, and even wearable devices. This diversification of product offerings caters to the varying preferences and needs of customers, allowing them to find a sleep aid that suits their lifestyle and preferences.

Local special circumstances:
Northern Europe has a well-developed healthcare system and a high level of healthcare awareness among its population. This has led to a greater emphasis on self-care and proactive health management. As a result, individuals are more likely to seek out sleep aids from pharmacies rather than relying solely on prescription medications or medical professionals. This preference for over-the-counter sleep aids has contributed to the growth of the Sleep Aids (Pharmacies) market in the region.

Underlying macroeconomic factors:
The Sleep Aids (Pharmacies) market in Northern Europe is also influenced by underlying macroeconomic factors. The region has a stable economy and a high standard of living, which enables individuals to afford sleep aids as part of their healthcare routine. Additionally, the aging population in Northern Europe is also driving the demand for sleep aids, as older individuals are more likely to experience sleep-related issues and seek out solutions to improve their sleep quality. In conclusion, the Sleep Aids (Pharmacies) market in Northern Europe is experiencing growth due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. The increasing demand for sleep aids, particularly natural and herbal products, is driven by the high-stress levels and busy lifestyles of individuals in the region. The availability of sleep aids in different forms and the emphasis on self-care contribute to the market's growth. Furthermore, the stable economy and aging population in Northern Europe also play a role in driving the demand for sleep aids.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)